The EmsanaRx Plus supplemental drug discount product represents a transition for Cost Plus Drugs from operating exclusively in the direct-to-consumer market into the employer market.
The medication treats depression, panic attacks, obsessive-compulsive disorder, bulimia and a severe form of premenstrual syndrome (premenstrual dysphoric disorder).
A report by the International Pharmaceutical Federation calls for formalized and quality education on sports pharmacy for a system of credentialling sports pharmacists.